First-of-its-kind cell sorting technology supports researchers advancing new therapies
24th Jan 2023: Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Bigfoot Spectral Cell Sorter in India. The first-of-its-kind cell sorting technology provides easy to use, high-speed cell sorting by complimenting conventional with spectral sorting and analysis.
Cell sorting enables scientists to isolate live, homogenous cell populations to answer critical questions regarding cellular changes that take place under certain conditions, stem cell differentiation, and cellular response to drugs. These insights are useful in genome editing, vaccine studies, drug and toxicity screening, and cell and gene therapy development, among other applications.
The Bigfoot Spectral Cell Sorter was designed to address challenges faced by researchers, offering unique benefits including:
· Speed at scale: The instrument accelerates sorting up to ten times faster than competitors.
· Versatility of detection: Bigfoot Spectral Cell Sorter can be configured with up to nine lasers and 60 detectors, providing adaptability for both standard fluorescence detection and spectral unmixing.
· Personnel and product protection: A custom-designed, built-in safety enclosure and an aerosol management system (AMS) provide safety and protection in a compact footprint.
“Growing interest in areas of immuno-oncology, purification of engineered microbes and vaccine development has increased demand for cytometry analysis and sorting techniques with greater multiplexing capabilities. The Bigfoot Spectral Cell Sorter addresses researchers’ need to gain deeper biological insights and advance their work in the development of new therapies”, said Amit Chopra, managing director, India and South Asia, Thermo Fisher Scientific.
Thermo Fisher acquired cell sorting technology assets from Propel Labs, a wholly-owned subsidiary of SIDIS Corp, in 2021
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
